0001144204-12-057130.txt : 20121022
0001144204-12-057130.hdr.sgml : 20121022
20121022134650
ACCESSION NUMBER: 0001144204-12-057130
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506
FILED AS OF DATE: 20121022
DATE AS OF CHANGE: 20121022
EFFECTIVENESS DATE: 20121022
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Synthetic Biologics, Inc.
CENTRAL INDEX KEY: 0000894158
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133808303
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-185905
FILM NUMBER: 121154319
BUSINESS ADDRESS:
STREET 1: 3985 RESEARCH PARK DRIVE,
STREET 2: SUITE 200
CITY: ANN ARBOR
STATE: MI
ZIP: 48108
BUSINESS PHONE: (734) 332-7800
MAIL ADDRESS:
STREET 1: 3985 RESEARCH PARK DRIVE,
STREET 2: SUITE 200
CITY: ANN ARBOR
STATE: MI
ZIP: 48108
FORMER COMPANY:
FORMER CONFORMED NAME: ADEONA PHARMACEUTICALS, INC.
DATE OF NAME CHANGE: 20081027
FORMER COMPANY:
FORMER CONFORMED NAME: PIPEX PHARMACEUTICALS, INC.
DATE OF NAME CHANGE: 20061214
FORMER COMPANY:
FORMER CONFORMED NAME: SHEFFIELD PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19970730
D
1
primary_doc.xml
X0706
D
LIVE
0000894158
Synthetic Biologics, Inc.
617 DETROIT STREET,
SUITE 100
ANN ARBOR
MI
MICHIGAN
48104
(734) 332-7800
NEVADA
Adeona Pharmaceuticals, Inc.
ADEONA PHARMACEUTICALS, INC.
PIPEX PHARMACEUTICALS, INC.
SHEFFIELD PHARMACEUTICALS INC
Corporation
true
Jeffrey
Riley
c/o Synthetic Biologics
617 Detroit Avenue, Suite 100
Ann Arbor
MI
MICHIGAN
48104
Executive Officer
Director
C.
Evan
Ballantyne
c/o Synthetic Biologics
617 Detroit Avenue, Suite 100
Ann Arbor
MI
MICHIGAN
48104
Executive Officer
Jeffrey
J.
Kraws
c/o Synthetic Biologics
617 Detroit Avenue, Suite 100
Ann Arbor
MI
MICHIGAN
48104
Director
Jeffrey
Wolf
c/o Synthetic Biologics
617 Detroit Avenue, Suite 100
Ann Arbor
MI
MICHIGAN
48104
Director
Steve
H.
Kanzer
c/o Synthetic Biologics
617 Detroit Avenue, Suite 100
Ann Arbor
MI
MICHIGAN
48104
Director
Scott
L.
Tarriff
c/o Synthetic Biologics
617 Detroit Avenue, Suite 100
Ann Arbor
MI
MICHIGAN
48104
Director
Biotechnology
Decline to Disclose
- 06
false
2012-10-16
false
true
false
0
7637252
7637252
0
The Company issued 3,552,210 shares of common stock to Intrexon Corp. pursuant to an Exclusive Channel Collaboration Agreement. No cash was received. The amount entered is based solely on the closing price of the Company's stock of $2.15 on 10/16/12.
false
1
0
0
0
false
Synthetic Biologics, Inc.
/s/ Jeffrey Riley
Jeffrey Riley
President and Chief Executive Officer
2012-10-22